Trials / Completed
CompletedNCT03678610
Handling Medium for ICSI With Ionomycin and Latrunculin A
Latrunculin A and Ionomycin as a Handling Medium for ICSI
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (actual)
- Sponsor
- Ibn Sina Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Using Latrunculin A and Ionomycin would improve the outcome of ICSI if the handling medium during the ICSI procedure has them.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A | Ionomycin and Latrunculin A would activate oocyte during ICSI along with cytoskeleton stabilization for a favourable outcomes |
Timeline
- Start date
- 2018-09-25
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2018-09-19
- Last updated
- 2019-05-07
Locations
3 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03678610. Inclusion in this directory is not an endorsement.